[
  {
    "title": "上海医药(601607.SH)：吸入用硫酸沙丁胺醇溶液获得注册批准",
    "href": "http://stock.jrj.com.cn/2022/12/29161137246408.shtml",
    "datetime": "2022-12-29 16:11:43",
    "code": "601607"
  },
  {
    "title": "A股异动丨上海医药涨5.54% 与平安盐野义达成战略合作 加速推进新冠口服药物Ensitrelvir在国内上市",
    "href": "http://stock.jrj.com.cn/2022/12/26094237237185.shtml",
    "datetime": "2022-12-26 09:42:08",
    "code": "601607"
  },
  {
    "title": "上海医药(601607.SH)：与平安盐野义就抗新冠病毒口服药物Ensitrelvir的进口品签订进口分销协议",
    "href": "http://stock.jrj.com.cn/2022/12/23174537234747.shtml",
    "datetime": "2022-12-23 17:45:52",
    "code": "601607"
  },
  {
    "title": "上海医药：上药控股将作为Ensitrelvir的进口品在中国大陆地区的独家进口商和经销商",
    "href": "http://stock.jrj.com.cn/2022/12/23174237234668.shtml",
    "datetime": "2022-12-23 17:42:55",
    "code": "601607"
  },
  {
    "title": "上海医药：子公司上药云健康有代理销售阿兹夫定和Paxlovid",
    "href": "http://stock.jrj.com.cn/2022/12/23134937233844.shtml",
    "datetime": "2022-12-23 13:49:02",
    "code": "601607"
  },
  {
    "title": "上海医药(601607.SH)：子公司枸橼酸托法替布片获批生产",
    "href": "http://stock.jrj.com.cn/2022/12/15160937215140.shtml",
    "datetime": "2022-12-15 16:09:27",
    "code": "601607"
  },
  {
    "title": "上海医药：上海上实长三角取得华源集团持有的上药集团40%股东全部权益",
    "href": "http://stock.jrj.com.cn/2022/11/18161437150073.shtml",
    "datetime": "2022-11-18 16:14:03",
    "code": "601607"
  },
  {
    "title": "上海医药(601607.SH)：上海上实长三角通过竞拍取得上药集团40%的股权",
    "href": "http://stock.jrj.com.cn/2022/11/18161237150101.shtml",
    "datetime": "2022-11-18 16:12:40",
    "code": "601607"
  },
  {
    "title": "上海医药(601607.SH)：多品种债务融资工具(DFI)注册申请获准",
    "href": "http://stock.jrj.com.cn/2022/11/09162037124173.shtml",
    "datetime": "2022-11-09 16:20:23",
    "code": "601607"
  },
  {
    "title": "上海医药(601607.SH)：甲磺酸雷沙吉兰舌下膜获批开展临床试验",
    "href": "http://stock.jrj.com.cn/2022/11/02165337106888.shtml",
    "datetime": "2022-11-02 16:53:18",
    "code": "601607"
  },
  {
    "title": "港股异动 | 上海医药AH股齐涨 H股升8%创3个半月新高",
    "href": "http://stock.jrj.com.cn/2022/11/02110437105720.shtml",
    "datetime": "2022-11-02 11:04:55",
    "code": "601607"
  },
  {
    "title": "上海医药：拉考沙胺片获得批准生产",
    "href": "http://stock.jrj.com.cn/2022/10/31163137099932.shtml",
    "datetime": "2022-10-31 16:31:47",
    "code": "601607"
  },
  {
    "title": "上海医药(601607.SH)：上药第一生化的拉考沙胺片获批生产",
    "href": "http://stock.jrj.com.cn/2022/10/31162437099926.shtml",
    "datetime": "2022-10-31 16:24:52",
    "code": "601607"
  },
  {
    "title": "上海医药(601607.SH)：第三季度净利增22.02%至11.18亿元",
    "href": "http://stock.jrj.com.cn/2022/10/27195937091016.shtml",
    "datetime": "2022-10-27 19:59:38",
    "code": "601607"
  },
  {
    "title": "上海医药(601607.SH)：上药禾丰的呋塞米注射液通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2022/10/26143637085331.shtml",
    "datetime": "2022-10-26 14:36:16",
    "code": "601607"
  },
  {
    "title": "上海医药(601607.SH)：上药信谊的华法林钠片通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2022/09/26153637021442.shtml",
    "datetime": "2022-09-26 15:36:42",
    "code": "601607"
  },
  {
    "title": "上海医药：“SPH3127片”II期临床试验获批",
    "href": "http://stock.jrj.com.cn/2022/09/08184536984045.shtml",
    "datetime": "2022-09-08 18:45:29",
    "code": "601607"
  },
  {
    "title": "上海医药(02607.HK)：SPH3127片获得II期临床试验批准通知书",
    "href": "http://stock.jrj.com.cn/2022/09/08173536983723.shtml",
    "datetime": "2022-09-08 17:35:19",
    "code": "601607"
  },
  {
    "title": "上海医药(02607.HK)获上实集团增持130万股",
    "href": "http://stock.jrj.com.cn/2022/09/07065836978658.shtml",
    "datetime": "2022-09-07 06:58:04",
    "code": "601607"
  },
  {
    "title": "上海医药(601607.SH)：拟出资5亿元参设前沿创新中心 其将开展从新靶点发现到Ⅱ期临床研究的创新研发工作",
    "href": "http://stock.jrj.com.cn/2022/09/06170836977224.shtml",
    "datetime": "2022-09-06 17:08:40",
    "code": "601607"
  },
  {
    "title": "上海医药：控股股东上实集团拟在未来一年内继续增持公司H股",
    "href": "http://stock.jrj.com.cn/2022/09/06110836976200.shtml",
    "datetime": "2022-09-06 11:08:53",
    "code": "601607"
  },
  {
    "title": "上海医药(601607.SH)：控股股东拟实施下一轮H股增持计划",
    "href": "http://stock.jrj.com.cn/2022/09/05173836974215.shtml",
    "datetime": "2022-09-05 17:38:53",
    "code": "601607"
  },
  {
    "title": "上海医药：重组抗CD20人源化单克隆抗体皮下注射液获得临床试验批准通知书",
    "href": "http://stock.jrj.com.cn/2022/09/05114736973172.shtml",
    "datetime": "2022-09-05 11:47:46",
    "code": "601607"
  },
  {
    "title": "中金：下调上海医药(2607.HK)目标价至16.1港元，评级“跑赢行业”",
    "href": "http://stock.jrj.com.cn/2022/08/30161236952781.shtml",
    "datetime": "2022-08-30 16:12:45",
    "code": "601607"
  },
  {
    "title": "上海医药2022年中报：收入与利润双增长 抗疫经营两为功",
    "href": "http://stock.jrj.com.cn/2022/08/30091936951150.shtml",
    "datetime": "2022-08-30 09:19:18",
    "code": "601607"
  },
  {
    "title": "上海医药(601607.SH)：上半年增3.58%至净利润36.96亿元",
    "href": "http://stock.jrj.com.cn/2022/08/29225236949698.shtml",
    "datetime": "2022-08-29 22:52:46",
    "code": "601607"
  },
  {
    "title": "上海医药：上半年净利润37亿元 同比增3.58%",
    "href": "http://stock.jrj.com.cn/2022/08/29183236948266.shtml",
    "datetime": "2022-08-29 18:32:20",
    "code": "601607"
  },
  {
    "title": "上海医药(02607.HK)：B013注射剂获得II/III期临床试验批准通知书",
    "href": "http://stock.jrj.com.cn/2022/08/23061136923664.shtml",
    "datetime": "2022-08-23 06:11:34",
    "code": "601607"
  },
  {
    "title": "上海医药(601607.SH)：阿立哌唑口服溶液获批生产",
    "href": "http://stock.jrj.com.cn/2022/08/15163936900406.shtml",
    "datetime": "2022-08-15 16:39:57",
    "code": "601607"
  },
  {
    "title": "上海医药(601607.SH)：叶酸片通过一致性评价",
    "href": "http://stock.jrj.com.cn/2022/08/04161136870355.shtml",
    "datetime": "2022-08-04 16:11:58",
    "code": "601607"
  },
  {
    "title": "上海医药：子公司常州制药厂的药品替格瑞洛片获批生产",
    "href": "http://stock.jrj.com.cn/2022/07/17190036818636.shtml",
    "datetime": "2022-07-17 19:00:16",
    "code": "601607"
  },
  {
    "title": "上海医药(601607.SH)：2021年度权益分派10派4.2元 股权登记日为7月21日",
    "href": "http://stock.jrj.com.cn/2022/07/15200636817140.shtml",
    "datetime": "2022-07-15 20:06:32",
    "code": "601607"
  },
  {
    "title": "上海医药(601607.SH)：常州制药厂的替格瑞洛片获得批准生产",
    "href": "http://stock.jrj.com.cn/2022/07/15162436816033.shtml",
    "datetime": "2022-07-15 16:24:26",
    "code": "601607"
  },
  {
    "title": "上海医药(02607.HK)获上实集团增持19.09万股",
    "href": "http://stock.jrj.com.cn/2022/07/12070136802026.shtml",
    "datetime": "2022-07-12 07:01:00",
    "code": "601607"
  },
  {
    "title": "大摩：予上海医药“增持”评级，目标价降至19.1港元",
    "href": "http://stock.jrj.com.cn/2022/06/21112136745518.shtml",
    "datetime": "2022-06-21 11:21:25",
    "code": "601607"
  },
  {
    "title": "上海医药(601607.SH)：盐酸克林霉素胶囊通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2022/06/17161236738102.shtml",
    "datetime": "2022-06-17 16:12:08",
    "code": "601607"
  },
  {
    "title": "上海医药(601607.SH)：上药新亚与轩竹生物及其子公司就百纳培南项目、Plazomicin项目进行合作",
    "href": "http://stock.jrj.com.cn/2022/06/16171836735031.shtml",
    "datetime": "2022-06-16 17:18:36",
    "code": "601607"
  },
  {
    "title": "上海医药(601607.SH)：阿哌沙班片获批生产",
    "href": "http://stock.jrj.com.cn/2022/06/06175836706311.shtml",
    "datetime": "2022-06-06 17:58:39",
    "code": "601607"
  },
  {
    "title": "上海医药(02607.HK)获上实集团增持68万股",
    "href": "http://stock.jrj.com.cn/2022/05/30065236687780.shtml",
    "datetime": "2022-05-30 06:52:02",
    "code": "601607"
  },
  {
    "title": "港股异动 | 上海医药跌6% 一季度净利润降40.99%",
    "href": "http://stock.jrj.com.cn/2022/05/03100036541119.shtml",
    "datetime": "2022-05-03 10:00:11",
    "code": "601607"
  },
  {
    "title": "上海医药2022年首季归母净利12.51亿元，同比下降近41%",
    "href": "http://stock.jrj.com.cn/2022/04/29161236504705.shtml",
    "datetime": "2022-04-29 16:12:36",
    "code": "601607"
  },
  {
    "title": "上海医药(601607.SH)：一季度净利润降40.99%至12.51亿元",
    "href": "http://stock.jrj.com.cn/2022/04/29143036503954.shtml",
    "datetime": "2022-04-29 14:30:43",
    "code": "601607"
  },
  {
    "title": "上海医药(02607.HK)遭花旗减持38.71万股",
    "href": "http://stock.jrj.com.cn/2022/04/22072636425488.shtml",
    "datetime": "2022-04-22 07:26:20",
    "code": "601607"
  },
  {
    "title": "东吴证券点评上海医药：医药商业和工业持续增长 重点布局创新药+中药+疫苗三大领域",
    "href": "http://stock.jrj.com.cn/hotstock/2022/04/19084036393802.shtml",
    "datetime": "2022-04-19 08:40:13",
    "code": "601607"
  },
  {
    "title": "上海医药(02607.HK)4月28日举行董事会会议审批一季度业绩",
    "href": "http://stock.jrj.com.cn/2022/04/13163436324064.shtml",
    "datetime": "2022-04-13 16:34:53",
    "code": "601607"
  },
  {
    "title": "上海医药拟定增近140亿元，战略投资者云南白药认购逾百亿",
    "href": "http://stock.jrj.com.cn/2022/04/07114336267337.shtml",
    "datetime": "2022-04-07 11:43:59",
    "code": "601607"
  },
  {
    "title": "140亿定增完成发行 上海医药牵手云南白药开启新征程",
    "href": "http://stock.jrj.com.cn/2022/04/06222836265035.shtml",
    "datetime": "2022-04-06 22:28:34",
    "code": "601607"
  },
  {
    "title": "港股异动丨上海医药AH股齐升 去年净利同比增13.28% 营收突破2千亿",
    "href": "http://stock.jrj.com.cn/2022/03/31101336230670.shtml",
    "datetime": "2022-03-31 10:13:01",
    "code": "601607"
  },
  {
    "title": "上海医药2021年报：营收突破2100亿，净利润超50亿",
    "href": "http://stock.jrj.com.cn/2022/03/30162736197639.shtml",
    "datetime": "2022-03-30 16:27:36",
    "code": "601607"
  },
  {
    "title": "上海医药2021年净利50.93亿同比增长13.28% 财务总监沈波薪酬543.44万",
    "href": "http://stock.jrj.com.cn/2022/03/30105236185458.shtml",
    "datetime": "2022-03-30 10:52:44",
    "code": "601607"
  },
  {
    "title": "上海医药(02607.HK)年度归母净利50.93亿元 同比增长13.28%",
    "href": "http://stock.jrj.com.cn/2022/03/30085236181232.shtml",
    "datetime": "2022-03-30 08:52:23",
    "code": "601607"
  },
  {
    "title": "上海医药(601607.SH)：拟发行余额不超150亿元的债务融资产品",
    "href": "http://stock.jrj.com.cn/2022/03/30011436166224.shtml",
    "datetime": "2022-03-30 01:14:33",
    "code": "601607"
  },
  {
    "title": "上海医药(601607.SH)：拟公开发行面值总额不超50亿元公司债券",
    "href": "http://stock.jrj.com.cn/2022/03/30011136166225.shtml",
    "datetime": "2022-03-30 01:11:08",
    "code": "601607"
  },
  {
    "title": "上海医药(601607.SH)2021年度净利润升13.28%至50.93亿元 拟10派4.2元",
    "href": "http://stock.jrj.com.cn/2022/03/30003936164830.shtml",
    "datetime": "2022-03-30 00:39:11",
    "code": "601607"
  },
  {
    "title": "上海医药(601607.SH)：甲硫酸新斯的明注射液通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2022/03/25175935123959.shtml",
    "datetime": "2022-03-25 17:59:52",
    "code": "601607"
  },
  {
    "title": "上海医药(601607.SH)：非公开发行A股股票申请获中国证监会核准",
    "href": "http://stock.jrj.com.cn/2022/03/22183134861639.shtml",
    "datetime": "2022-03-22 18:31:12",
    "code": "601607"
  },
  {
    "title": "上海医药(02607.HK)获花旗增持30.15万股",
    "href": "http://stock.jrj.com.cn/2022/03/22082434859072.shtml",
    "datetime": "2022-03-22 08:24:40",
    "code": "601607"
  },
  {
    "title": "上海医药(601607.SH)：并未与盐野义制药在新冠病毒治疗药物方面开展合作",
    "href": "http://stock.jrj.com.cn/2022/03/21193334857136.shtml",
    "datetime": "2022-03-21 19:33:55",
    "code": "601607"
  },
  {
    "title": "上海医药：未开展与盐野义制药在新冠病毒治疗药物合作",
    "href": "http://stock.jrj.com.cn/2022/03/21191534857042.shtml",
    "datetime": "2022-03-21 19:15:05",
    "code": "601607"
  },
  {
    "title": "【龙虎榜】上海医药3月21日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/03/21180634856628.shtml",
    "datetime": "2022-03-21 18:06:56",
    "code": "601607"
  },
  {
    "title": "《新型冠状病毒肺炎诊疗方案（试行第九版）》发布 上海医药多项药物助力疫情防治",
    "href": "http://stock.jrj.com.cn/2022/03/20191734870996.shtml",
    "datetime": "2022-03-20 19:17:44",
    "code": "601607"
  },
  {
    "title": "《新型冠状病毒肺炎诊疗方案（试行第九版）》发布 上海医药多项药物助力疫情防治",
    "href": "http://stock.jrj.com.cn/2022/03/20191734865491.shtml",
    "datetime": "2022-03-20 19:17:44",
    "code": "601607"
  },
  {
    "title": "《新型冠状病毒肺炎诊疗方案（试行第九版）》发布 上海医药多项药物助力疫情防治",
    "href": "http://stock.jrj.com.cn/2022/03/20191734868178.shtml",
    "datetime": "2022-03-20 19:17:44",
    "code": "601607"
  },
  {
    "title": "《新型冠状病毒肺炎诊疗方案（试行第九版）》发布 上海医药多项药物助力疫情防治",
    "href": "http://stock.jrj.com.cn/2022/03/20191734869559.shtml",
    "datetime": "2022-03-20 19:17:44",
    "code": "601607"
  },
  {
    "title": "《新型冠状病毒肺炎诊疗方案（试行第九版）》发布 上海医药多项药物助力疫情防治",
    "href": "http://stock.jrj.com.cn/2022/03/20191734852463.shtml",
    "datetime": "2022-03-20 19:17:44",
    "code": "601607"
  },
  {
    "title": "《新型冠状病毒肺炎诊疗方案（试行第九版）》发布 上海医药多项药物助力疫情防治",
    "href": "http://stock.jrj.com.cn/2022/03/20191734864712.shtml",
    "datetime": "2022-03-20 19:17:44",
    "code": "601607"
  },
  {
    "title": "《新型冠状病毒肺炎诊疗方案（试行第九版）》发布 上海医药多项药物助力疫情防治",
    "href": "http://stock.jrj.com.cn/2022/03/20191734866798.shtml",
    "datetime": "2022-03-20 19:17:44",
    "code": "601607"
  },
  {
    "title": "上海医药(02607.HK)：非公开发行A股申请获得通过",
    "href": "http://stock.jrj.com.cn/2022/03/14175434824789.shtml",
    "datetime": "2022-03-14 17:54:10",
    "code": "601607"
  },
  {
    "title": "上海医药(601607.SH)：非公开发行A股股票申请获证监会审核通过",
    "href": "http://stock.jrj.com.cn/2022/03/14172434824535.shtml",
    "datetime": "2022-03-14 17:24:22",
    "code": "601607"
  },
  {
    "title": "上海医药(02607.HK)：盐酸氟桂利嗪胶囊通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2022/03/03165734516328.shtml",
    "datetime": "2022-03-03 16:57:30",
    "code": "601607"
  },
  {
    "title": "上海医药(601607.SH)：盐酸氟桂利嗪胶囊通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2022/03/03163134516150.shtml",
    "datetime": "2022-03-03 16:31:30",
    "code": "601607"
  },
  {
    "title": "上海医药(02607.HK)：抗心绞痛药盐酸胺碘酮片通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2022/03/01173434508702.shtml",
    "datetime": "2022-03-01 17:34:37",
    "code": "601607"
  },
  {
    "title": "上海医药(601607.SH)：子公司盐酸胺碘酮片通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2022/03/01171234508560.shtml",
    "datetime": "2022-03-01 17:12:47",
    "code": "601607"
  },
  {
    "title": "上海医药(601607.SH)：子公司盐酸胺碘酮注射液获得批准生产",
    "href": "http://stock.jrj.com.cn/2022/02/11170434323857.shtml",
    "datetime": "2022-02-11 17:04:50",
    "code": "601607"
  },
  {
    "title": "上海医药(02607.HK)获Shanghai Industrial Investment增持35.8万股",
    "href": "http://stock.jrj.com.cn/2022/02/07065534297658.shtml",
    "datetime": "2022-02-07 06:55:19",
    "code": "601607"
  },
  {
    "title": "上海医药(601607.SH)：硫酸羟氯喹片通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2022/01/28162134242957.shtml",
    "datetime": "2022-01-28 16:21:14",
    "code": "601607"
  },
  {
    "title": "上海医药(601607.SH)：子公司磷酸奥司他韦胶囊通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2022/01/19164634174315.shtml",
    "datetime": "2022-01-19 16:46:51",
    "code": "601607"
  },
  {
    "title": "极光UMS助力上海医药 高效赋能医药服务创新",
    "href": "http://stock.jrj.com.cn/2022/01/13154434153866.shtml",
    "datetime": "2022-01-13 15:44:21",
    "code": "601607"
  },
  {
    "title": "上海医药(02607.HK)：盐酸氟桂利嗪胶囊通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2022/01/11170034146459.shtml",
    "datetime": "2022-01-11 17:00:48",
    "code": "601607"
  },
  {
    "title": "上海医药(601607.SH)：盐酸氟桂利嗪胶囊通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2022/01/11163634146297.shtml",
    "datetime": "2022-01-11 16:36:46",
    "code": "601607"
  },
  {
    "title": "上海医药(601607.SH)：766.722万份股票期权拟行权",
    "href": "http://stock.jrj.com.cn/2022/01/05210434126483.shtml",
    "datetime": "2022-01-05 21:04:09",
    "code": "601607"
  },
  {
    "title": "上海医药(601607.SH)：替米沙坦片通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2021/12/23160934052850.shtml",
    "datetime": "2021-12-23 16:09:35",
    "code": "601607"
  },
  {
    "title": "上海医药(601607.SH)：SPH4336片获得美国FDA药品II期临床试验批准",
    "href": "http://stock.jrj.com.cn/2021/12/20163134034702.shtml",
    "datetime": "2021-12-20 16:31:24",
    "code": "601607"
  },
  {
    "title": "上海医药：卡马西平片及盐酸地尔硫片通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2021/12/10163033994786.shtml",
    "datetime": "2021-12-10 16:30:37",
    "code": "601607"
  },
  {
    "title": "上海医药(601607.SH)：利伐沙班片获批生产",
    "href": "http://stock.jrj.com.cn/2021/12/08161933984989.shtml",
    "datetime": "2021-12-08 16:19:21",
    "code": "601607"
  },
  {
    "title": "上海医药(601607.SH)：子公司的氯氮平片通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2021/11/25161133919052.shtml",
    "datetime": "2021-11-25 16:11:34",
    "code": "601607"
  },
  {
    "title": "上海医药(601607.SH)：“重组抗CD20人源化单克隆抗体注射液”将于近期启动Ib期临床试验",
    "href": "http://stock.jrj.com.cn/2021/11/18163033872776.shtml",
    "datetime": "2021-11-18 16:30:11",
    "code": "601607"
  },
  {
    "title": "上海医药(02607.HK)获Shanghai Industrial Investment增持40万股",
    "href": "http://stock.jrj.com.cn/2021/11/15061933851956.shtml",
    "datetime": "2021-11-15 06:19:21",
    "code": "601607"
  },
  {
    "title": "上海医药：与Phagelux公司就抗细菌感染新药ClyO项目进行合作",
    "href": "http://stock.jrj.com.cn/2021/11/04165833813121.shtml",
    "datetime": "2021-11-04 16:58:49",
    "code": "601607"
  },
  {
    "title": "上海医药(601607.SH)：与Phagelux公司就抗细菌感染新药ClyO项目进行合作",
    "href": "http://stock.jrj.com.cn/2021/11/04165133813104.shtml",
    "datetime": "2021-11-04 16:51:14",
    "code": "601607"
  },
  {
    "title": "上海医药(02607.HK)：前三季净利44.84亿元 同比增长24.49%",
    "href": "http://stock.jrj.com.cn/2021/10/29170533778033.shtml",
    "datetime": "2021-10-29 17:05:48",
    "code": "601607"
  },
  {
    "title": "上海医药(601607.SH)：第三季度净利降20.94%至9.16亿元",
    "href": "http://stock.jrj.com.cn/2021/10/29165933777879.shtml",
    "datetime": "2021-10-29 16:59:04",
    "code": "601607"
  },
  {
    "title": "License out！超2.9亿美元上海医药SPH6162海外授权落地",
    "href": "http://stock.jrj.com.cn/2021/10/29103733775886.shtml",
    "datetime": "2021-10-29 10:37:07",
    "code": "601607"
  },
  {
    "title": "License-in再下一城 上海医药拟不超1.07亿美元引进KoBioLabs两款益生菌新药",
    "href": "http://stock.jrj.com.cn/2021/10/28102633767727.shtml",
    "datetime": "2021-10-28 10:26:28",
    "code": "601607"
  },
  {
    "title": "上海医药(02607.HK)与KoBioLabs公司就益生菌KBL697、KBL693项目进行合作",
    "href": "http://stock.jrj.com.cn/2021/10/27174533762594.shtml",
    "datetime": "2021-10-27 17:45:42",
    "code": "601607"
  },
  {
    "title": "上海医药：子公司与KoBioLabs公司就益生菌KBL697、KBL693项目进行合作",
    "href": "http://stock.jrj.com.cn/2021/10/27172633762392.shtml",
    "datetime": "2021-10-27 17:26:30",
    "code": "601607"
  },
  {
    "title": "切入中国抑酸市场 上海医药6.9亿引进重磅新药",
    "href": "http://stock.jrj.com.cn/2021/10/08220633659747.shtml",
    "datetime": "2021-10-08 22:06:00",
    "code": "601607"
  },
  {
    "title": "上海医药(601607.SH)：与贵州生诺就新型抑酸剂X842项目开展战略合作",
    "href": "http://stock.jrj.com.cn/2021/10/08174733658370.shtml",
    "datetime": "2021-10-08 17:47:32",
    "code": "601607"
  },
  {
    "title": "上海医药(02607.HK)获Shanghai Industrial Investment增持20.2万股",
    "href": "http://stock.jrj.com.cn/2021/09/24074133508211.shtml",
    "datetime": "2021-09-24 07:41:22",
    "code": "601607"
  },
  {
    "title": "上海医药(601607.SH)：子公司盐酸多巴胺注射液及盐酸利多卡因注射液通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2021/09/13165633428772.shtml",
    "datetime": "2021-09-13 16:56:03",
    "code": "601607"
  },
  {
    "title": "上海医药(601607.SH)：子公司的枸橼酸咖啡因注射液获得批准生产",
    "href": "http://stock.jrj.com.cn/2021/09/13165333428764.shtml",
    "datetime": "2021-09-13 16:53:16",
    "code": "601607"
  },
  {
    "title": "上海医药(601607.SH)：控股股东增持21.28万股H股",
    "href": "http://stock.jrj.com.cn/2021/09/03180833381159.shtml",
    "datetime": "2021-09-03 18:08:05",
    "code": "601607"
  },
  {
    "title": "上海医药(02607.HK)：上实集团增持5257.07万股H股 增持计划实施完毕",
    "href": "http://stock.jrj.com.cn/2021/09/01174933368582.shtml",
    "datetime": "2021-09-01 17:49:22",
    "code": "601607"
  },
  {
    "title": "上海医药(601607.SH)：上实集团累计增持1.857%股份 增持实施完毕",
    "href": "http://stock.jrj.com.cn/2021/09/01170933368306.shtml",
    "datetime": "2021-09-01 17:09:58",
    "code": "601607"
  },
  {
    "title": "上海医药(02607.HK)：抗肿瘤药SPH6516片获临试批准通知书",
    "href": "http://stock.jrj.com.cn/2021/08/31173333362213.shtml",
    "datetime": "2021-08-31 17:33:25",
    "code": "601607"
  },
  {
    "title": "上海医药(601607.SH)：SPH6516片开展晚期恶性实体瘤的临床试验获批",
    "href": "http://stock.jrj.com.cn/2021/08/31170833362008.shtml",
    "datetime": "2021-08-31 17:08:02",
    "code": "601607"
  },
  {
    "title": "上海医药2021年半年度净利35.68亿元 同比净利增加46.05%",
    "href": "http://stock.jrj.com.cn/2021/08/31125333360042.shtml",
    "datetime": "2021-08-31 12:53:16",
    "code": "601607"
  },
  {
    "title": "上海医药(601607.SH)半年度净利润35.68亿元 同比增长46.05%",
    "href": "http://stock.jrj.com.cn/2021/08/30171933353020.shtml",
    "datetime": "2021-08-30 17:19:25",
    "code": "601607"
  },
  {
    "title": "上海医药(02607.HK)：中国证监会受理公司建议非公开发行A股",
    "href": "http://stock.jrj.com.cn/2021/08/25175333317589.shtml",
    "datetime": "2021-08-25 17:53:44",
    "code": "601607"
  },
  {
    "title": "上海雷允上药品公司门店违法被罚 为上海医药子公司",
    "href": "http://stock.jrj.com.cn/2021/08/17163733267196.shtml",
    "datetime": "2021-08-17 16:37:00",
    "code": "601607"
  },
  {
    "title": "上海医药：战投方案获股东大会高票通过 合作共赢再启新征程",
    "href": "http://stock.jrj.com.cn/2021/08/14093433252210.shtml",
    "datetime": "2021-08-14 09:34:27",
    "code": "601607"
  },
  {
    "title": "上海医药(02607.HK)：SPH3127片新适应症获得II期临试批准通知书",
    "href": "http://stock.jrj.com.cn/2021/08/03174033196665.shtml",
    "datetime": "2021-08-03 17:40:21",
    "code": "601607"
  },
  {
    "title": "上海医药(601607.SH)：SPH3127片新适应症获II期临床试验批准通知书",
    "href": "http://stock.jrj.com.cn/2021/08/03165833195403.shtml",
    "datetime": "2021-08-03 16:58:42",
    "code": "601607"
  },
  {
    "title": "上海医药(02607.HK)获Shanghai Industrial Investment增持200.83万股",
    "href": "http://stock.jrj.com.cn/2021/08/02065933186255.shtml",
    "datetime": "2021-08-02 06:59:56",
    "code": "601607"
  },
  {
    "title": "上海医药(02607.HK)获Shanghai Industrial Investment增持77.82万股",
    "href": "http://stock.jrj.com.cn/2021/07/26062733149583.shtml",
    "datetime": "2021-07-26 06:27:14",
    "code": "601607"
  },
  {
    "title": "上海医药(02607.HK)：梁瑞冰获委任为联席公司秘书",
    "href": "http://stock.jrj.com.cn/2021/07/23184533141362.shtml",
    "datetime": "2021-07-23 18:45:25",
    "code": "601607"
  },
  {
    "title": "上海医药(02607.HK)拟出资9000万元参与设立生物医药产业专项基金",
    "href": "http://stock.jrj.com.cn/2021/07/23184333141358.shtml",
    "datetime": "2021-07-23 18:43:50",
    "code": "601607"
  },
  {
    "title": "上海医药(601607.SH)：拟出资9000万元参设生物医药产业专项基金",
    "href": "http://stock.jrj.com.cn/2021/07/23183233141324.shtml",
    "datetime": "2021-07-23 18:32:31",
    "code": "601607"
  },
  {
    "title": "上海医药(02607.HK)：晚期实体瘤治疗药品SPH5030片获临试批准通知书",
    "href": "http://stock.jrj.com.cn/2021/07/22165533135672.shtml",
    "datetime": "2021-07-22 16:55:05",
    "code": "601607"
  },
  {
    "title": "上海医药(601607.SH)：SPH5030片获临床试验批准通知书",
    "href": "http://stock.jrj.com.cn/2021/07/22162333135468.shtml",
    "datetime": "2021-07-22 16:23:43",
    "code": "601607"
  },
  {
    "title": "上海医药(02607.HK)：普瑞巴林胶囊获得美国FDA批准文号",
    "href": "http://stock.jrj.com.cn/2021/07/19165533119586.shtml",
    "datetime": "2021-07-19 16:55:02",
    "code": "601607"
  },
  {
    "title": "上海医药(601607.SH)：普瑞巴林胶囊获得美国FDA批准文号",
    "href": "http://stock.jrj.com.cn/2021/07/19163133119417.shtml",
    "datetime": "2021-07-19 16:31:14",
    "code": "601607"
  },
  {
    "title": "康希诺(688185.SH)：上药康希诺拟向上海医药方面借调部分人员为其提供技术咨询、综合管理等服务",
    "href": "http://stock.jrj.com.cn/2021/07/16172433108190.shtml",
    "datetime": "2021-07-16 17:24:07",
    "code": "601607"
  },
  {
    "title": "上海医药(601607.SH)：子公司的注射用帕瑞昔布钠获得批准生产",
    "href": "http://stock.jrj.com.cn/2021/07/14175733095604.shtml",
    "datetime": "2021-07-14 17:57:38",
    "code": "601607"
  },
  {
    "title": "上海医药(601607.SH)2020年度A股权益分派10派4.8元 股权登记日为7月16日",
    "href": "http://stock.jrj.com.cn/2021/07/13151433089081.shtml",
    "datetime": "2021-07-13 15:14:34",
    "code": "601607"
  },
  {
    "title": "上海医药(601607.SH)：2020年度权益分派10派0.2元 股权登记日7月9日",
    "href": "http://stock.jrj.com.cn/2021/07/05220733049343.shtml",
    "datetime": "2021-07-05 22:07:30",
    "code": "601607"
  },
  {
    "title": "上海医药(02607.HK)：艾司唑仑片通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2021/07/05170633047846.shtml",
    "datetime": "2021-07-05 17:06:15",
    "code": "601607"
  },
  {
    "title": "上海医药(601607.SH):SPH6516片临床试验申请获受理",
    "href": "http://stock.jrj.com.cn/2021/06/28171033010619.shtml",
    "datetime": "2021-06-28 17:10:47",
    "code": "601607"
  },
  {
    "title": "上海医药(02607.HK)：SPH6516片临床试验申请获得受理",
    "href": "http://stock.jrj.com.cn/2021/06/28165133010516.shtml",
    "datetime": "2021-06-28 16:51:04",
    "code": "601607"
  },
  {
    "title": "上海医药(601607.SH)：甲硝唑片通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2021/06/25173032997161.shtml",
    "datetime": "2021-06-25 17:30:33",
    "code": "601607"
  },
  {
    "title": "上海医药：引入战投云南白药加速体制机制创新 有望进一步激发企业活力与增长潜力",
    "href": "http://stock.jrj.com.cn/2021/06/25141832996077.shtml",
    "datetime": "2021-06-25 14:18:51",
    "code": "601607"
  },
  {
    "title": "上海医药(601607.SH)：注射用头孢曲松钠及注射用兰索拉唑通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2021/06/23165832983509.shtml",
    "datetime": "2021-06-23 16:58:03",
    "code": "601607"
  },
  {
    "title": "上海医药(02607.HK)：瑞舒伐他汀钙片获得批准生产",
    "href": "http://stock.jrj.com.cn/2021/06/16174732941393.shtml",
    "datetime": "2021-06-16 17:47:18",
    "code": "601607"
  },
  {
    "title": "上海医药(601607.SH)：瑞舒伐他汀钙片获批生产",
    "href": "http://stock.jrj.com.cn/2021/06/16172232941220.shtml",
    "datetime": "2021-06-16 17:22:13",
    "code": "601607"
  },
  {
    "title": "上海医药(601607.SH)：A股定增方案获上实集团批复",
    "href": "http://stock.jrj.com.cn/2021/06/16171832941201.shtml",
    "datetime": "2021-06-16 17:18:35",
    "code": "601607"
  },
  {
    "title": "上海医药非公开发行引入战投云南白药 发力医药工业与医药商业双赛道",
    "href": "http://stock.jrj.com.cn/2021/06/11175132912712.shtml",
    "datetime": "2021-06-11 17:51:00",
    "code": "601607"
  },
  {
    "title": "上海医药(02607.HK)：盐酸度洛西汀肠溶片通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2021/06/07164832887279.shtml",
    "datetime": "2021-06-07 16:48:55",
    "code": "601607"
  },
  {
    "title": "上海医药(601607.SH)：盐酸度洛西汀肠溶片通过一致性评价",
    "href": "http://stock.jrj.com.cn/2021/06/07161532887054.shtml",
    "datetime": "2021-06-07 16:15:01",
    "code": "601607"
  },
  {
    "title": "上海医药：拟受让控股股东全资子公司100%股权",
    "href": "http://stock.jrj.com.cn/2021/05/28060432832838.shtml",
    "datetime": "2021-05-28 06:04:32",
    "code": "601607"
  },
  {
    "title": "上海医药(02607.HK)：聘任卢烨和孙诗旖担任证券事务代表",
    "href": "http://stock.jrj.com.cn/2021/05/27190532831350.shtml",
    "datetime": "2021-05-27 19:05:05",
    "code": "601607"
  },
  {
    "title": "上海医药(601607.SH)：拟7.5亿元受让上药生物医药100%股权",
    "href": "http://stock.jrj.com.cn/2021/05/27183832831126.shtml",
    "datetime": "2021-05-27 18:38:25",
    "code": "601607"
  },
  {
    "title": "上海医药(02607.HK)：艾司唑仑片通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2021/05/20170132787676.shtml",
    "datetime": "2021-05-20 17:01:24",
    "code": "601607"
  },
  {
    "title": "上海医药(601607.SH)：艾司唑仑片通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2021/05/20161132787419.shtml",
    "datetime": "2021-05-20 16:11:52",
    "code": "601607"
  },
  {
    "title": "上海医药(601607.SH)：“SPH3127片”慢性肾病适应症临床申请获受理",
    "href": "http://stock.jrj.com.cn/2021/05/19163332782065.shtml",
    "datetime": "2021-05-19 16:33:32",
    "code": "601607"
  },
  {
    "title": "上海医药(601607.SH)：辛伐他汀片通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2021/05/18171832776769.shtml",
    "datetime": "2021-05-18 17:18:25",
    "code": "601607"
  },
  {
    "title": "上海医药拟定增不超143.8亿 云南白药认购八成深化产业合作",
    "href": "http://stock.jrj.com.cn/2021/05/13073932746044.shtml",
    "datetime": "2021-05-13 07:39:52",
    "code": "601607"
  },
  {
    "title": "上海医药(02607.HK)：西咪替丁片及培哚普利叔丁胺片通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2021/05/12165532742552.shtml",
    "datetime": "2021-05-12 16:55:03",
    "code": "601607"
  },
  {
    "title": "上海医药(601607.SH)：西咪替丁片及培哚普利叔丁胺片通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2021/05/12162832742379.shtml",
    "datetime": "2021-05-12 16:28:10",
    "code": "601607"
  },
  {
    "title": "上海医药拟定增集资143.84亿元，云南白药将持股逾18%为二股东",
    "href": "http://stock.jrj.com.cn/2021/05/12145432741890.shtml",
    "datetime": "2021-05-12 14:54:27",
    "code": "601607"
  },
  {
    "title": "上海医药拟定增不超144亿 并引入云南白药为战略投资者",
    "href": "http://stock.jrj.com.cn/2021/05/12094832740389.shtml",
    "datetime": "2021-05-12 09:48:14",
    "code": "601607"
  },
  {
    "title": "AH股齐跌！上海医药A股大跌超7% 锁价定增引入云南白药",
    "href": "http://stock.jrj.com.cn/2021/05/12093832740239.shtml",
    "datetime": "2021-05-12 09:38:53",
    "code": "601607"
  },
  {
    "title": "云南白药(000538.SZ)：拟以不超112.29亿元战略入股上海医药 持股达18.02%",
    "href": "http://stock.jrj.com.cn/2021/05/11223232737881.shtml",
    "datetime": "2021-05-11 22:32:05",
    "code": "601607"
  },
  {
    "title": "上海医药(601607.SH)拟定增募资不超143.84亿元 由上海潭东及云南白药认购",
    "href": "http://stock.jrj.com.cn/2021/05/11204932737149.shtml",
    "datetime": "2021-05-11 20:49:06",
    "code": "601607"
  },
  {
    "title": "上海医药：拟定增引入云南白药作为战略投资者",
    "href": "http://stock.jrj.com.cn/2021/05/11203032737064.shtml",
    "datetime": "2021-05-11 20:30:40",
    "code": "601607"
  },
  {
    "title": "上海医药(02607.HK)获SIIC INTERNATIONAL INVESTMENT增持50万股",
    "href": "http://stock.jrj.com.cn/2021/05/10062132725512.shtml",
    "datetime": "2021-05-10 06:21:27",
    "code": "601607"
  },
  {
    "title": "上海医药(601607.SH)一季度净利润升104.24%至21.20亿元",
    "href": "http://stock.jrj.com.cn/2021/04/28154232471595.shtml",
    "datetime": "2021-04-28 15:42:32",
    "code": "601607"
  },
  {
    "title": "上药控股黄山公司遭安徽限期整改 为上海医药旗下企业",
    "href": "http://stock.jrj.com.cn/2021/04/22151932423138.shtml",
    "datetime": "2021-04-22 15:19:00",
    "code": "601607"
  },
  {
    "title": "上海医药(02607.HK)：阿立哌唑通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2021/04/09180032343507.shtml",
    "datetime": "2021-04-09 18:00:19",
    "code": "601607"
  },
  {
    "title": "上海医药(601607.SH)：阿立哌唑通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2021/04/09165032342827.shtml",
    "datetime": "2021-04-09 16:50:08",
    "code": "601607"
  },
  {
    "title": "上海医药(02607.HK)：B001-A临床试验申请获得受理",
    "href": "http://stock.jrj.com.cn/2021/03/30182732248970.shtml",
    "datetime": "2021-03-30 18:27:08",
    "code": "601607"
  },
  {
    "title": "上海医药(601607.SH)拟发行余额不超200亿元债务融资产品",
    "href": "http://stock.jrj.com.cn/2021/03/26221632224829.shtml",
    "datetime": "2021-03-26 22:16:34",
    "code": "601607"
  },
  {
    "title": "上海医药(601607.SH)拟发行总额不超200亿元公司债",
    "href": "http://stock.jrj.com.cn/2021/03/26221332224824.shtml",
    "datetime": "2021-03-26 22:13:44",
    "code": "601607"
  },
  {
    "title": "上海医药(601607.SH)2020年度净利润升10.17%至44.96亿元 拟10派4.8元",
    "href": "http://stock.jrj.com.cn/2021/03/26185032223871.shtml",
    "datetime": "2021-03-26 18:50:11",
    "code": "601607"
  },
  {
    "title": "上海医药(02607.HK)拟计提商誉减值准备4.86亿元",
    "href": "http://stock.jrj.com.cn/2021/03/23175832202666.shtml",
    "datetime": "2021-03-23 17:58:11",
    "code": "601607"
  },
  {
    "title": "上海医药(601607.SH)：拟计提商誉减值准备金额合计约4.86亿元",
    "href": "http://stock.jrj.com.cn/2021/03/23164132202011.shtml",
    "datetime": "2021-03-23 16:41:44",
    "code": "601607"
  },
  {
    "title": "上海医药聘任陈津竹为公司副总裁",
    "href": "http://stock.jrj.com.cn/2021/03/05172732079020.shtml",
    "datetime": "2021-03-05 17:27:14",
    "code": "601607"
  },
  {
    "title": "上海医药(02607.HK)：聘任陈津竹为公司副总裁",
    "href": "http://stock.jrj.com.cn/2021/03/04182232072144.shtml",
    "datetime": "2021-03-04 18:22:17",
    "code": "601607"
  },
  {
    "title": "上海医药(601607.SH)拟聘任陈津竹为公司副总裁",
    "href": "http://stock.jrj.com.cn/2021/03/04170432071534.shtml",
    "datetime": "2021-03-04 17:04:06",
    "code": "601607"
  },
  {
    "title": "入股疫苗研发生产公司 上海医药A股逼近涨停 H股涨超7%",
    "href": "http://stock.jrj.com.cn/2021/02/26103632031627.shtml",
    "datetime": "2021-02-26 10:36:20",
    "code": "601607"
  },
  {
    "title": "上海医药(601607.SH)：Prolgolimab 注射液获批III期临床试验",
    "href": "http://stock.jrj.com.cn/2021/02/22164232006367.shtml",
    "datetime": "2021-02-22 16:42:49",
    "code": "601607"
  },
  {
    "title": "上海医药(601607.SH)：阿莫西林胶囊通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2021/02/09180231878380.shtml",
    "datetime": "2021-02-09 18:02:05",
    "code": "601607"
  },
  {
    "title": "上海医药：公司已在上海、北京、成都、本溪、香港、圣地亚哥、费城等全球多地布局研发平台",
    "href": "http://stock.jrj.com.cn/2021/02/01100231827746.shtml",
    "datetime": "2021-02-01 10:02:57",
    "code": "601607"
  },
  {
    "title": "上海医药：“创新”已经成为当前上海医药的四大战略举措之首",
    "href": "http://stock.jrj.com.cn/2021/02/01100231827744.shtml",
    "datetime": "2021-02-01 10:02:55",
    "code": "601607"
  },
  {
    "title": "上海医药：公司参与集采的8个品种中有6个品种（7个品规）中标",
    "href": "http://stock.jrj.com.cn/2021/02/01100131827735.shtml",
    "datetime": "2021-02-01 10:01:37",
    "code": "601607"
  },
  {
    "title": "上海医药：上海医药已形成“线上+线下”的闭环",
    "href": "http://stock.jrj.com.cn/2021/02/01100131827733.shtml",
    "datetime": "2021-02-01 10:01:03",
    "code": "601607"
  },
  {
    "title": "天宝药业违规遭重庆药监局警告 为上海医药旗下企业",
    "href": "http://stock.jrj.com.cn/2021/01/28134831800773.shtml",
    "datetime": "2021-01-28 13:48:00",
    "code": "601607"
  },
  {
    "title": "中华药业使用化妆品禁用原料遭立案 为上海医药子公司",
    "href": "http://stock.jrj.com.cn/2021/01/28134631800774.shtml",
    "datetime": "2021-01-28 13:46:00",
    "code": "601607"
  },
  {
    "title": "上海医药(601607.SH)与永发印务集团签订采购框架协议",
    "href": "http://stock.jrj.com.cn/2021/01/19171131722533.shtml",
    "datetime": "2021-01-19 17:11:42",
    "code": "601607"
  },
  {
    "title": "上海医药(601607.SH)：头孢拉定胶囊通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2021/01/06175331642512.shtml",
    "datetime": "2021-01-06 17:53:41",
    "code": "601607"
  },
  {
    "title": "上海医药(02607.HK)：盐酸二甲双胍片及硝酸甘油片通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2021/01/04181331628156.shtml",
    "datetime": "2021-01-04 18:13:14",
    "code": "601607"
  },
  {
    "title": "上海医药(601607.SH)：盐酸二甲双胍片及硝酸甘油片通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2021/01/04174931627961.shtml",
    "datetime": "2021-01-04 17:49:36",
    "code": "601607"
  },
  {
    "title": "重庆通报7批次药品不合规 含上海医药子公司中药饮片",
    "href": "http://stock.jrj.com.cn/2020/12/30183931606257.shtml",
    "datetime": "2020-12-30 18:39:00",
    "code": "601607"
  },
  {
    "title": "上海医药(02607.HK)：SPH3127获得美国FDA药品II期临床试验资格",
    "href": "http://stock.jrj.com.cn/2020/12/30165131605286.shtml",
    "datetime": "2020-12-30 16:51:38",
    "code": "601607"
  },
  {
    "title": "上海医药(601607.SH)：向28名激励对象授予273万份预留股票期权",
    "href": "http://stock.jrj.com.cn/2020/12/15180931495576.shtml",
    "datetime": "2020-12-15 18:09:19",
    "code": "601607"
  },
  {
    "title": "上海医药(02607.HK)：催眠或焦虑辅助用药阿普唑仑片通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2020/12/11173331465632.shtml",
    "datetime": "2020-12-11 17:33:24",
    "code": "601607"
  },
  {
    "title": "上海医药(601607.SH)：阿普唑仑片通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2020/12/11170331465478.shtml",
    "datetime": "2020-12-11 17:03:23",
    "code": "601607"
  },
  {
    "title": "上海医药：2020年前三季度疫苗配送业务收入39.7亿元 同比增长62.58%",
    "href": "http://stock.jrj.com.cn/2020/12/03160831400359.shtml",
    "datetime": "2020-12-03 16:08:12",
    "code": "601607"
  },
  {
    "title": "上海医药(601607.SH)：盐酸贝那普利片及盐酸度洛西汀肠溶胶囊通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2020/12/02161531393041.shtml",
    "datetime": "2020-12-02 16:15:07",
    "code": "601607"
  },
  {
    "title": "上海医药：重组抗CD20人源化单克隆抗体皮下注射液临床试验申请获受理",
    "href": "http://stock.jrj.com.cn/2020/11/30221131378731.shtml",
    "datetime": "2020-11-30 22:11:50",
    "code": "601607"
  },
  {
    "title": "辽宁药监局公示行政检查 整改涉上海医药海思科子公司",
    "href": "http://stock.jrj.com.cn/2020/11/27173731361499.shtml",
    "datetime": "2020-11-27 17:37:00",
    "code": "601607"
  },
  {
    "title": "上海医药：2020年前三季度主要财务指标",
    "href": "http://stock.jrj.com.cn/2020/10/30004031161782.shtml",
    "datetime": "2020-10-30 00:40:14",
    "code": "601607"
  },
  {
    "title": "上海医药短期融资券发行 总额为25亿元",
    "href": "http://stock.jrj.com.cn/2020/10/21202931102609.shtml",
    "datetime": "2020-10-21 20:29:49",
    "code": "601607"
  },
  {
    "title": "上海医药(02607.HK)遭全国社会保障基金理事会减持35.29万股",
    "href": "http://stock.jrj.com.cn/2020/10/15084431057744.shtml",
    "datetime": "2020-10-15 08:44:19",
    "code": "601607"
  },
  {
    "title": "上海医药(601607.SH)：瑞舒伐他汀钙片获药品注册证书",
    "href": "http://stock.jrj.com.cn/2020/09/22171630810352.shtml",
    "datetime": "2020-09-22 17:16:29",
    "code": "601607"
  },
  {
    "title": "上海医药：目前已经在原料药、制剂等多个领域与科研院所等机构开展产-学-研深度合作",
    "href": "http://stock.jrj.com.cn/2020/09/21161230803001.shtml",
    "datetime": "2020-09-21 16:12:40",
    "code": "601607"
  },
  {
    "title": "上海医药(601607.SH)：盐酸克林霉素胶囊通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2020/09/14161430748051.shtml",
    "datetime": "2020-09-14 16:14:25",
    "code": "601607"
  },
  {
    "title": "上海医药(02607.HK)遭全国社会保障基金理事会减持173.65万股",
    "href": "http://stock.jrj.com.cn/2020/09/14074430744893.shtml",
    "datetime": "2020-09-14 07:44:10",
    "code": "601607"
  },
  {
    "title": "科创板医药生物上市公司中期业绩亮眼 上海医药与康希诺生物联手推进疫苗产业化及供应链服务 | 医资日报",
    "href": "http://stock.jrj.com.cn/2020/09/01182230654494.shtml",
    "datetime": "2020-09-01 18:22:08",
    "code": "601607"
  },
  {
    "title": "[康希诺]康希诺生物与上海医药签署战略合作 携手推进疫苗产业贯通及供应保障",
    "href": "http://stock.jrj.com.cn/2020/09/01000031147810.shtml",
    "datetime": "2020-09-01 00:00:00",
    "code": "601607"
  },
  {
    "title": "[康希诺]康希诺生物与上海医药签署战略合作 携手推进疫苗产业贯通及供应保障",
    "href": "http://stock.jrj.com.cn/2020/09/01000031029798.shtml",
    "datetime": "2020-09-01 00:00:00",
    "code": "601607"
  },
  {
    "title": "康希诺生物与上海医药签署战略合作",
    "href": "http://stock.jrj.com.cn/2020/08/31222030646565.shtml",
    "datetime": "2020-08-31 22:20:00",
    "code": "601607"
  },
  {
    "title": "上海医药业绩全面复苏 二季度净利润同比环比皆增",
    "href": "http://stock.jrj.com.cn/2020/08/28170630614992.shtml",
    "datetime": "2020-08-28 17:06:31",
    "code": "601607"
  },
  {
    "title": "[九洲药业]九洲药业:携手上海医药,开创合作新模式,构建原料药与制剂一体化格局",
    "href": "http://stock.jrj.com.cn/2020/08/28000031032253.shtml",
    "datetime": "2020-08-28 00:00:00",
    "code": "601607"
  },
  {
    "title": "上海医药2020年上半年净利24.43亿增长6.84% 总体业务逐步恢复",
    "href": "http://stock.jrj.com.cn/2020/08/27215530606983.shtml",
    "datetime": "2020-08-27 21:55:24",
    "code": "601607"
  },
  {
    "title": "全球500强榜单出炉 上海医药首度强势入榜",
    "href": "http://stock.jrj.com.cn/2020/08/10230330468495.shtml",
    "datetime": "2020-08-10 23:03:09",
    "code": "601607"
  },
  {
    "title": "丽珠集团拟分拆丽珠试剂A股上市 上海医药首次进入《财富》世界500强榜单 | 医资日报",
    "href": "http://stock.jrj.com.cn/2020/08/10185830467433.shtml",
    "datetime": "2020-08-10 18:58:05",
    "code": "601607"
  },
  {
    "title": "上海医药短期融资券发行 总额为25亿元",
    "href": "http://stock.jrj.com.cn/2020/07/28193530365559.shtml",
    "datetime": "2020-07-28 19:35:13",
    "code": "601607"
  },
  {
    "title": "上海医药工商业协同增速加速 探路地方国企高质量发展 | 聚焦国内医药生物产业重要公司",
    "href": "http://stock.jrj.com.cn/2020/07/27162930355326.shtml",
    "datetime": "2020-07-27 16:29:05",
    "code": "601607"
  },
  {
    "title": "上海医药：2019年年度股东大会、2020年第一次A股类别股东大会及2020年第一次H股类别股东大会决议公告",
    "href": "http://stock.jrj.com.cn/2020/06/24000030002551.shtml",
    "datetime": "2020-06-24 00:00:08",
    "code": "601607"
  },
  {
    "title": "上海医药：注射用LT3001临床试验申请获得受理",
    "href": "http://stock.jrj.com.cn/2020/06/22173629989732.shtml",
    "datetime": "2020-06-22 17:36:00",
    "code": "601607"
  },
  {
    "title": "上海医药10年打造全产业链核心优势 两年投入29亿研发聚焦药品创新",
    "href": "http://stock.jrj.com.cn/2020/06/22072729985531.shtml",
    "datetime": "2020-06-22 07:27:24",
    "code": "601607"
  },
  {
    "title": "上海医药：控股子公司产品获得美国FDA暂时批文",
    "href": "http://stock.jrj.com.cn/2020/06/18202029959199.shtml",
    "datetime": "2020-06-18 20:20:00",
    "code": "601607"
  },
  {
    "title": "上海医药参股公司复旦张江首次公开发行A股股票并在科创板上市发行",
    "href": "http://stock.jrj.com.cn/2020/06/09085529877818.shtml",
    "datetime": "2020-06-09 08:55:41",
    "code": "601607"
  },
  {
    "title": "上海医药：SPH4336片获得临床试验通知书",
    "href": "http://stock.jrj.com.cn/2020/06/01190229817115.shtml",
    "datetime": "2020-06-01 19:02:00",
    "code": "601607"
  },
  {
    "title": "上海医药子公司氯氮平片通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2020/05/30015129799609.shtml",
    "datetime": "2020-05-30 01:51:08",
    "code": "601607"
  },
  {
    "title": "上海医药：氯氮平片通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2020/05/29171029796807.shtml",
    "datetime": "2020-05-29 17:10:00",
    "code": "601607"
  },
  {
    "title": "上海医药短期融资券发行总额为25亿元",
    "href": "http://stock.jrj.com.cn/2020/05/04170029536602.shtml",
    "datetime": "2020-05-04 17:00:02",
    "code": "601607"
  },
  {
    "title": "上海医药2020年第一季度净利10.38亿下滑7.84% 拆迁补偿减少",
    "href": "http://stock.jrj.com.cn/2020/04/30115729429639.shtml",
    "datetime": "2020-04-30 11:57:51",
    "code": "601607"
  },
  {
    "title": "上海医药一季度实现净利逾10亿元",
    "href": "http://stock.jrj.com.cn/2020/04/28181629406465.shtml",
    "datetime": "2020-04-28 18:16:11",
    "code": "601607"
  },
  {
    "title": "福建九仁堂销售白及抽验不合规 上海医药间接持股",
    "href": "http://stock.jrj.com.cn/2020/04/14172629284399.shtml",
    "datetime": "2020-04-14 17:26:00",
    "code": "601607"
  },
  {
    "title": "[绿地控股]绿地携手上中医及上海医药共建全球领先生物医药、医用物资产业园",
    "href": "http://stock.jrj.com.cn/2020/04/13000029274567.shtml",
    "datetime": "2020-04-13 00:00:00",
    "code": "601607"
  },
  {
    "title": "绿地集团与上海中医药大学、上海医药签署战略合作协议",
    "href": "http://stock.jrj.com.cn/2020/04/09192329248579.shtml",
    "datetime": "2020-04-09 19:23:00",
    "code": "601607"
  },
  {
    "title": "上海医药：盐酸氨溴索胶囊及卡托普利片通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2020/04/07183629227382.shtml",
    "datetime": "2020-04-07 18:36:00",
    "code": "601607"
  },
  {
    "title": "上海医药：SPH4336片临床试验申请获得受理",
    "href": "http://stock.jrj.com.cn/2020/03/30170229147641.shtml",
    "datetime": "2020-03-30 17:02:00",
    "code": "601607"
  },
  {
    "title": "上海医药：2019年年度主要财务指标",
    "href": "http://stock.jrj.com.cn/2020/03/28001029131328.shtml",
    "datetime": "2020-03-28 00:10:34",
    "code": "601607"
  },
  {
    "title": "上海医药：第七届董事会第十次会议决议公告",
    "href": "http://stock.jrj.com.cn/2020/03/28001029131329.shtml",
    "datetime": "2020-03-28 00:10:34",
    "code": "601607"
  },
  {
    "title": "上海医药2019年年报：扣非净利增长超30% 工商业利润双超20亿",
    "href": "http://stock.jrj.com.cn/2020/03/27221529130508.shtml",
    "datetime": "2020-03-27 22:15:00",
    "code": "601607"
  },
  {
    "title": "上海医药2019年扣非后净利同比增逾三成 拟10派4.4元",
    "href": "http://stock.jrj.com.cn/2020/03/27213229130198.shtml",
    "datetime": "2020-03-27 21:32:09",
    "code": "601607"
  },
  {
    "title": "上海医药：2019年净利同比增长5% 拟10派4.4元",
    "href": "http://stock.jrj.com.cn/2020/03/27203729129802.shtml",
    "datetime": "2020-03-27 20:37:37",
    "code": "601607"
  },
  {
    "title": "上海医药：2019年净利同比增5% 拟10派4.4元",
    "href": "http://stock.jrj.com.cn/2020/03/27202529129763.shtml",
    "datetime": "2020-03-27 20:25:00",
    "code": "601607"
  },
  {
    "title": "江西一药房三家分店抽检不符合规定 股东现上海医药",
    "href": "http://stock.jrj.com.cn/2020/03/26164329118711.shtml",
    "datetime": "2020-03-26 16:43:00",
    "code": "601607"
  },
  {
    "title": "上海医药：第七届董事会第九次会议决议公告",
    "href": "http://stock.jrj.com.cn/2020/03/20231029072480.shtml",
    "datetime": "2020-03-20 23:10:25",
    "code": "601607"
  },
  {
    "title": "上海医药：计提商誉减值准备7.05亿元",
    "href": "http://stock.jrj.com.cn/2020/03/20155029069594.shtml",
    "datetime": "2020-03-20 15:50:54",
    "code": "601607"
  },
  {
    "title": "上海医药：子公司盐酸二甲双胍片通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2020/03/16171129033491.shtml",
    "datetime": "2020-03-16 17:11:33",
    "code": "601607"
  },
  {
    "title": "上海医药：盐酸二甲双胍片通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2020/03/16162329033179.shtml",
    "datetime": "2020-03-16 16:23:01",
    "code": "601607"
  },
  {
    "title": "上海医药：控股子公司右佐匹克隆片通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2020/03/09165928981090.shtml",
    "datetime": "2020-03-09 16:59:54",
    "code": "601607"
  },
  {
    "title": "上海医药：右佐匹克隆片通过仿制药一致性评价 主要用于治疗失眠",
    "href": "http://stock.jrj.com.cn/2020/03/09162028980876.shtml",
    "datetime": "2020-03-09 16:20:16",
    "code": "601607"
  },
  {
    "title": "上海医药：右佐匹克隆片通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2020/03/09160128980050.shtml",
    "datetime": "2020-03-09 16:01:00",
    "code": "601607"
  },
  {
    "title": "冲在前干在先 上海医药全面助力抗疫",
    "href": "http://stock.jrj.com.cn/2020/03/02072928928458.shtml",
    "datetime": "2020-03-02 07:29:13",
    "code": "601607"
  },
  {
    "title": "上海医药2020年度第一期超短期融资券发行 总额为25亿",
    "href": "http://stock.jrj.com.cn/2020/02/29150628919816.shtml",
    "datetime": "2020-02-29 15:06:58",
    "code": "601607"
  },
  {
    "title": "[景峰医药]特殊时期关爱特殊人群,景峰医药支持上海医药行业协会向养老服务机构捐赠6000瓶消毒液",
    "href": "http://stock.jrj.com.cn/2020/02/17000028842075.shtml",
    "datetime": "2020-02-17 00:00:00",
    "code": "601607"
  },
  {
    "title": "左敏：上海医药正积极配合硫酸羟氯喹片抗新冠病毒的全国多中心临床研究工作",
    "href": "http://stock.jrj.com.cn/2020/02/15154528833345.shtml",
    "datetime": "2020-02-15 15:45:27",
    "code": "601607"
  },
  {
    "title": "上海医药执行董事兼总裁左敏：公司个别原料药供应受疫情影响，但暂未影响生产",
    "href": "http://stock.jrj.com.cn/2020/02/15150428833281.shtml",
    "datetime": "2020-02-15 15:04:42",
    "code": "601607"
  },
  {
    "title": "羟氯喹治疗新冠肺炎的临床试验已启动 上海医药尾盘异动",
    "href": "http://stock.jrj.com.cn/2020/02/13151328823588.shtml",
    "datetime": "2020-02-13 15:13:13",
    "code": "601607"
  },
  {
    "title": "部分医药股盘中拉升 上海医药涨超6%",
    "href": "http://stock.jrj.com.cn/2020/02/13144528823129.shtml",
    "datetime": "2020-02-13 14:45:00",
    "code": "601607"
  },
  {
    "title": "上海医药：第七届董事会第八次会议决议公告",
    "href": "http://stock.jrj.com.cn/2020/02/10214028804936.shtml",
    "datetime": "2020-02-10 21:40:05",
    "code": "601607"
  },
  {
    "title": "上海医药：下属上药信谊有生产利巴韦林气雾剂",
    "href": "http://stock.jrj.com.cn/2020/02/06144828783829.shtml",
    "datetime": "2020-02-06 14:48:00",
    "code": "601607"
  },
  {
    "title": "上海医药：全力抗击肺炎疫情 旗下各企业加班加点开展供应保障工作",
    "href": "http://stock.jrj.com.cn/2020/02/05224228778530.shtml",
    "datetime": "2020-02-05 22:42:25",
    "code": "601607"
  },
  {
    "title": "医疗队除夕驰援武汉 上海医药星夜运送物资",
    "href": "http://stock.jrj.com.cn/2020/02/05223928778529.shtml",
    "datetime": "2020-02-05 22:39:46",
    "code": "601607"
  },
  {
    "title": "上海医药：与吉利德科学就抗艾产品有战略合作关系",
    "href": "http://stock.jrj.com.cn/2020/02/04134628766479.shtml",
    "datetime": "2020-02-04 13:46:00",
    "code": "601607"
  },
  {
    "title": "上海医药：全力抗击肺炎疫情 旗下各企业加班加点开展供应保障工作",
    "href": "http://stock.jrj.com.cn/2020/01/25184228735417.shtml",
    "datetime": "2020-01-25 18:42:23",
    "code": "601607"
  },
  {
    "title": "医疗队除夕驰援武汉 上海医药星夜运送物资",
    "href": "http://stock.jrj.com.cn/2020/01/25183928735416.shtml",
    "datetime": "2020-01-25 18:39:23",
    "code": "601607"
  },
  {
    "title": "上海医药：SPH3261胶囊临床试验申请获受理",
    "href": "http://stock.jrj.com.cn/2020/01/22181328721849.shtml",
    "datetime": "2020-01-22 18:13:00",
    "code": "601607"
  },
  {
    "title": "上海医药：第七届董事会第七次会议决议公告",
    "href": "http://stock.jrj.com.cn/2019/12/19234028559375.shtml",
    "datetime": "2019-12-19 23:40:04",
    "code": "601607"
  },
  {
    "title": "上海医药：2019年第一次临时股东大会、2019年第二次A股类别股东大会及2019年第二次H股类别股东大会决议公告",
    "href": "http://stock.jrj.com.cn/2019/12/19034028553606.shtml",
    "datetime": "2019-12-19 03:40:09",
    "code": "601607"
  },
  {
    "title": "上海医药：下属控股子公司独家产品注射用尤瑞克林新纳入医保目录",
    "href": "http://stock.jrj.com.cn/2019/11/29182028469452.shtml",
    "datetime": "2019-11-29 18:20:31",
    "code": "601607"
  },
  {
    "title": "上海医药：子公司产品新纳入国家医保目录",
    "href": "http://stock.jrj.com.cn/2019/11/29181928469447.shtml",
    "datetime": "2019-11-29 18:19:00",
    "code": "601607"
  },
  {
    "title": "上海医药布洛芬缓释胶囊通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2019/11/21180028433123.shtml",
    "datetime": "2019-11-21 18:00:39",
    "code": "601607"
  },
  {
    "title": "上海医药下属控股子公司上药杏灵收到《药品GMP证书》",
    "href": "http://stock.jrj.com.cn/2019/11/15081928402913.shtml",
    "datetime": "2019-11-15 08:19:05",
    "code": "601607"
  },
  {
    "title": "上海医药：股票期权激励计划获上海市国资委批复",
    "href": "http://stock.jrj.com.cn/2019/11/11172028380689.shtml",
    "datetime": "2019-11-11 17:20:00",
    "code": "601607"
  },
  {
    "title": "上海医药下属控股子公司正大青春宝获得《药品GMP证书》",
    "href": "http://stock.jrj.com.cn/2019/11/07183528366885.shtml",
    "datetime": "2019-11-07 18:35:37",
    "code": "601607"
  },
  {
    "title": "上海医药：与顺天医药就LT3001项目进行合作",
    "href": "http://stock.jrj.com.cn/2019/11/06202528361792.shtml",
    "datetime": "2019-11-06 20:25:57",
    "code": "601607"
  },
  {
    "title": "上海医药：关于召开2019年第一次临时股东大会、2019年第二次A股类别股东大会的通知",
    "href": "http://stock.jrj.com.cn/2019/11/01155028339181.shtml",
    "datetime": "2019-11-01 15:50:01",
    "code": "601607"
  },
  {
    "title": "上海医药前三季度盈利33.99亿 同比增长0.8%",
    "href": "http://stock.jrj.com.cn/2019/10/31095828331509.shtml",
    "datetime": "2019-10-31 09:58:37",
    "code": "601607"
  },
  {
    "title": "上海医药：2019年前三季度主要财务指标",
    "href": "http://stock.jrj.com.cn/2019/10/31015028329440.shtml",
    "datetime": "2019-10-31 01:50:16",
    "code": "601607"
  },
  {
    "title": "上海医药：公开发行2018年公司债券（第一期）2019年付息公告",
    "href": "http://stock.jrj.com.cn/2019/10/31015028329441.shtml",
    "datetime": "2019-10-31 01:50:16",
    "code": "601607"
  },
  {
    "title": "上海医药：工、商业板块齐头并进 收入利润保持高增长",
    "href": "http://stock.jrj.com.cn/2019/10/30234828328765.shtml",
    "datetime": "2019-10-30 23:48:39",
    "code": "601607"
  },
  {
    "title": "上海医药：前三季度净利34亿元 同比微增0.8%",
    "href": "http://stock.jrj.com.cn/2019/10/30162928326184.shtml",
    "datetime": "2019-10-30 16:29:24",
    "code": "601607"
  },
  {
    "title": "上海医药：前三季净利33.99亿元 同比增0.8%",
    "href": "http://stock.jrj.com.cn/2019/10/30161328326119.shtml",
    "datetime": "2019-10-30 16:13:00",
    "code": "601607"
  },
  {
    "title": "上海医药盐酸多西环素胶囊及片剂获得美国FDA批准文号",
    "href": "http://stock.jrj.com.cn/2019/10/15193328251823.shtml",
    "datetime": "2019-10-15 19:33:56",
    "code": "601607"
  },
  {
    "title": "上海医药：盐酸多西环素胶囊及片剂获美国FDA批准文号",
    "href": "http://stock.jrj.com.cn/2019/10/15192628251793.shtml",
    "datetime": "2019-10-15 19:26:58",
    "code": "601607"
  },
  {
    "title": "上海医药：盐酸多西环素胶囊及片剂获得美国FDA批准文号",
    "href": "http://stock.jrj.com.cn/2019/10/15180528251105.shtml",
    "datetime": "2019-10-15 18:05:17",
    "code": "601607"
  },
  {
    "title": "上海医药：第七届董事会第五次会议决议公告",
    "href": "http://stock.jrj.com.cn/2019/09/30213028202391.shtml",
    "datetime": "2019-09-30 21:30:07",
    "code": "601607"
  },
  {
    "title": "上海医药：拟推2842万份股票期权激励计划",
    "href": "http://stock.jrj.com.cn/2019/09/30204828202307.shtml",
    "datetime": "2019-09-30 20:48:06",
    "code": "601607"
  },
  {
    "title": "上海医药控股子公司收到《药品GMP证书》",
    "href": "http://stock.jrj.com.cn/2019/09/24183228173855.shtml",
    "datetime": "2019-09-24 18:32:29",
    "code": "601607"
  },
  {
    "title": "上海医药：下属控股子公司获得药品GMP证书",
    "href": "http://stock.jrj.com.cn/2019/09/24170328173384.shtml",
    "datetime": "2019-09-24 17:03:03",
    "code": "601607"
  },
  {
    "title": "上海医药：控股子公司获得药品GMP证书",
    "href": "http://stock.jrj.com.cn/2019/09/24170228173399.shtml",
    "datetime": "2019-09-24 17:02:00",
    "code": "601607"
  },
  {
    "title": "[哈药股份]上海医药与BIOCAD设合资公司",
    "href": "http://stock.jrj.com.cn/2019/09/24000028173967.shtml",
    "datetime": "2019-09-24 00:00:00",
    "code": "601607"
  },
  {
    "title": "上海医药对外投资设立合资公司 合资公司注册资本4亿美元",
    "href": "http://stock.jrj.com.cn/invest/2019/09/18093428145238.shtml",
    "datetime": "2019-09-18 09:34:00",
    "code": "601607"
  },
  {
    "title": "上海医药：子公司与BIOCAD HK正式签署协议 将新设合资公司",
    "href": "http://stock.jrj.com.cn/2019/09/18085528144913.shtml",
    "datetime": "2019-09-18 08:55:00",
    "code": "601607"
  },
  {
    "title": "上海医药：2019年半年度主要财务指标",
    "href": "http://stock.jrj.com.cn/2019/08/29232028058357.shtml",
    "datetime": "2019-08-29 23:20:02",
    "code": "601607"
  },
  {
    "title": "上海医药：第七届董事会第二次会议决议公告",
    "href": "http://stock.jrj.com.cn/2019/08/29232028058358.shtml",
    "datetime": "2019-08-29 23:20:02",
    "code": "601607"
  },
  {
    "title": "上海医药：工业营收上百亿元台阶 工商业营收增速双超20%",
    "href": "http://stock.jrj.com.cn/2019/08/29214128058001.shtml",
    "datetime": "2019-08-29 21:41:49",
    "code": "601607"
  },
  {
    "title": "上海医药2019年上半年净利22.86亿 医药工业主营业务增长",
    "href": "http://stock.jrj.com.cn/2019/08/29170128056268.shtml",
    "datetime": "2019-08-29 17:01:36",
    "code": "601607"
  },
  {
    "title": "上海医药：上半年净利22.86亿元 同比增12.45%",
    "href": "http://stock.jrj.com.cn/2019/08/29162128056075.shtml",
    "datetime": "2019-08-29 16:21:00",
    "code": "601607"
  },
  {
    "title": "上海医药：上半年净利22.86亿元 同比增长12%",
    "href": "http://stock.jrj.com.cn/2019/08/29160228055939.shtml",
    "datetime": "2019-08-29 16:02:04",
    "code": "601607"
  },
  {
    "title": "上海医药牵手8家高校及医院科研院所 打造国际领先药企",
    "href": "http://stock.jrj.com.cn/2019/07/29201327900584.shtml",
    "datetime": "2019-07-29 20:13:38",
    "code": "601607"
  },
  {
    "title": "上海医药：2018年年度A股权益分派实施公告",
    "href": "http://stock.jrj.com.cn/2019/07/09011027811537.shtml",
    "datetime": "2019-07-09 01:10:01",
    "code": "601607"
  },
  {
    "title": "上海医药：第七届董事会第一次会议决议公告",
    "href": "http://stock.jrj.com.cn/2019/06/28001027766195.shtml",
    "datetime": "2019-06-28 00:10:04",
    "code": "601607"
  },
  {
    "title": "上海医药：2018年年度股东大会、2019年第一次A股类别股东大会及2019年第一次H股类别股东大会决议公告",
    "href": "http://stock.jrj.com.cn/2019/06/28001027766196.shtml",
    "datetime": "2019-06-28 00:10:04",
    "code": "601607"
  },
  {
    "title": "上海医药销售费达110亿：频并购负债增 百亿商誉悬顶",
    "href": "http://stock.jrj.com.cn/2019/06/17085527712861.shtml",
    "datetime": "2019-06-17 08:55:10",
    "code": "601607"
  },
  {
    "title": "上海医药：下属控股子公司获得药品GMP证书",
    "href": "http://stock.jrj.com.cn/2019/06/13211827701390.shtml",
    "datetime": "2019-06-13 21:18:34",
    "code": "601607"
  },
  {
    "title": "上海医药：控股子公司药品通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2019/06/10165827681311.shtml",
    "datetime": "2019-06-10 16:58:28",
    "code": "601607"
  },
  {
    "title": "上海医药：子公司药品通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2019/06/10165427681276.shtml",
    "datetime": "2019-06-10 16:54:23",
    "code": "601607"
  },
  {
    "title": "上海医药与BIOCAD正式签约",
    "href": "http://stock.jrj.com.cn/2019/06/06164827672619.shtml",
    "datetime": "2019-06-06 16:48:55",
    "code": "601607"
  },
  {
    "title": "上海医药：第六届董事会第二十五次会议决议公告",
    "href": "http://stock.jrj.com.cn/2019/05/29073027635529.shtml",
    "datetime": "2019-05-29 07:30:04",
    "code": "601607"
  },
  {
    "title": "上海医药：羟基雷公藤内酯醇片将启动Ⅱ期临床试验",
    "href": "http://stock.jrj.com.cn/2019/05/20170827596127.shtml",
    "datetime": "2019-05-20 17:08:23",
    "code": "601607"
  },
  {
    "title": "社保基金连续3个季度加仓19只潜力股 扎堆两行业",
    "href": "http://stock.jrj.com.cn/2019/05/18013327588178.shtml",
    "datetime": "2019-05-18 01:33:46",
    "code": "601607"
  },
  {
    "title": "上海医药：全资子公司获得药品GMP证书",
    "href": "http://stock.jrj.com.cn/2019/05/16185427582576.shtml",
    "datetime": "2019-05-16 18:54:26",
    "code": "601607"
  },
  {
    "title": "复旦张江冲刺科创板 上海医药持股22.77%",
    "href": "http://stock.jrj.com.cn/2019/05/13210127565403.shtml",
    "datetime": "2019-05-13 21:01:00",
    "code": "601607"
  }
]